NATURAL-KILLER AND LYMPHOKINE ACTIVATED KILLER-CELL FUNCTIONS IN HODGKINS-DISEASE

被引:10
作者
RAJARAM, N
TATAKE, RJ
ADVANI, SH
GANGAL, SG
机构
[1] CANC RES INST,DIV IMMUNOL,BOMBAY 400012,INDIA
[2] TATE MEM HOSP,TATA MEM CTR,BOMBAY 400012,INDIA
关键词
D O I
10.1038/bjc.1990.261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the natural killer (NK) and lymphokine activated killer (LAK) cell activities in peripheral blood lymphocytes (PBL) from untreated patients with Hodgkin’s disease (HD) and from healthy donors. The frequency of LAK cell precursors was also studied using limiting dilution analysis (LDA). About 75% of the HD patients had normal NK activity. There was a higher percentage of low NK responders (mean percent NK activity of healthy donors - 2 SD) in patients with lymphocyte depletion histologic grade of the disease and those who were in clinical stage IV, suggesting a correlation of decrease in NK activity with poor prognosis. We found efficient LAK activity against the NK-sensitive K562 cells and NK-resistant VIP (melanoma) and T-24 (bladder carcinoma) tumour targets in both low and normal NK responder HD patients, irrespective of the histopathological grade and clinical stage of the disease. In concordance with their good LAK cell activity, HD patients showed a frequency distribution of LAK cell progenitors in the PBL comparable to that of healthy donors. © The MacMillan Press Ltd., 1990.
引用
收藏
页码:205 / 208
页数:4
相关论文
共 31 条
[1]   HODGKIN DISEASE - MALIGNANCY, INFLAMMATION AND ABNORMAL IMMUNITY [J].
AGHAI, E .
LEUKEMIA RESEARCH, 1986, 10 (11) :1267-1270
[2]  
BERENYI E, 1986, CANCER IMMUNOL IMMUN, V21, P164
[3]   NATURAL AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN CHRONIC MYELOID-LEUKEMIA PATIENTS IN REMISSION [J].
DABHOLKAR, M ;
ADVANI, S ;
TATAKE, R ;
GANGAL, S .
LEUKEMIA RESEARCH, 1986, 10 (02) :203-209
[4]   AFFINITY OF IL-2 RECEPTORS AND PROLIFERATION OF MITOGEN ACTIVATED LYMPHOCYTES IN HODGKINS-DISEASE [J].
DAMLE, RN ;
TATAKE, RJ ;
ADVANI, SH ;
GANGAL, SG .
BRITISH JOURNAL OF CANCER, 1990, 61 (03) :404-406
[5]   LYMPHOKINE ACTIVATED KILLING OF FRESH HUMAN LEUKEMIAS [J].
DAWSON, MM ;
JOHNSTON, D ;
TAYLOR, GM ;
MOORE, M .
LEUKEMIA RESEARCH, 1986, 10 (06) :683-688
[6]  
FRYDECKA I, 1985, CANCER-AM CANCER SOC, V56, P2799, DOI 10.1002/1097-0142(19851215)56:12<2799::AID-CNCR2820561215>3.0.CO
[7]  
2-W
[8]  
GANGAL SG, 1987, INDIAN J ALLERGY APP, V1, P3
[9]  
GRIMM EA, 1986, BIOCHIM BIOPHYS ACTA, V865, P267
[10]  
GULWANI BN, 1986, ONCOLOGY, V43, P149